Dr. Jan Drappatz
Overview
Jan Drappatz, MD, is a neuro-oncologist, an associate professor at the University of Pittsburgh School of Medicine, and the director of the Neuro-oncology program at UPMC. Dr. Drappatz specializes in the treatment of primary and metastatic brain tumors and neurologic complications of cancer.
Dr. Drappatz is rated as a Distinguished provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
His clinical research consists of co-authoring 82 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Additional Areas of Focus
Dr. Drappatz has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Frank Lieberman is a Neurologist in Pittsburgh, Pennsylvania. Dr. Lieberman is rated as an Elite provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
UPMC Hillman Cancer Center
Megan M. Mantica, MD, is an assistant professor of neurology and medicine at the University of Pittsburgh School of Medicine in the division of hematology/oncology. She specializes in the treatment of adult high grade gliomas, central nervous system lymphoma, and neurological complications of cancer treatment. Her translational research interests include womenís neuro-oncology, reproductive neuro-oncology and metastatic brain disease, and high grade gliomas. Dr. Mantica is rated as an Advanced provider by MediFind in the treatment of Ependymoma. Her top areas of expertise are Glioma, Brain Tumor, Glioblastoma, and Astrocytoma.
Dlp Conemaugh Physician Practices LLC
Henry Kesler is a Neurosurgery specialist and a Neurologist in Johnstown, Pennsylvania. Dr. Kesler is rated as an Advanced provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Neuroepithelioma, Pediatric Low-Grade Glioma (pLGG), Atypical Teratoid Rhabdoid Tumor (ATRT), Gliosarcoma, and Laminectomy. Dr. Kesler is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Drappatz isElite. Learn about Astrocytoma.
- Brain TumorDr. Drappatz isElite. Learn about Brain Tumor.
- GlioblastomaDr. Drappatz isElite. Learn about Glioblastoma.
- GliomaDr. Drappatz isElite. Learn about Glioma.
- Gliomatosis CerebriDr. Drappatz isElite. Learn about Gliomatosis Cerebri.
- Distinguished
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Drappatz isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Embryonal Tumor with Multilayered RosettesDr. Drappatz isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- EpendymomaDr. Drappatz isDistinguished. Learn about Ependymoma.
- GliosarcomaDr. Drappatz isDistinguished. Learn about Gliosarcoma.
- Metastatic Brain TumorDr. Drappatz isDistinguished. Learn about Metastatic Brain Tumor.
- NeuroepitheliomaDr. Drappatz isDistinguished. Learn about Neuroepithelioma.
- Advanced
- Brain Stem CancerDr. Drappatz isAdvanced. Learn about Brain Stem Cancer.
- Cerebral Ventricle CancerDr. Drappatz isAdvanced. Learn about Cerebral Ventricle Cancer.
- Choroid Plexus PapillomaDr. Drappatz isAdvanced. Learn about Choroid Plexus Papilloma.
- Diencephalic SyndromeDr. Drappatz isAdvanced. Learn about Diencephalic Syndrome.
- Diffuse Midline Glioma H3 K27M-MutantDr. Drappatz isAdvanced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.
- HemangioblastomaDr. Drappatz isAdvanced. Learn about Hemangioblastoma.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Drappatz isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- ArachnoiditisDr. Drappatz isExperienced. Learn about Arachnoiditis.
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- EpilepsyDr. Drappatz isExperienced. Learn about Epilepsy.
- Generalized Tonic-Clonic SeizureDr. Drappatz isExperienced. Learn about Generalized Tonic-Clonic Seizure.
- Memory LossDr. Drappatz isExperienced. Learn about Memory Loss.